Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Spruce Biosciences (SPRB) Interest & Investment Income (2022 - 2025)

Spruce Biosciences (SPRB) has disclosed Interest & Investment Income for 4 consecutive years, with -$40000.0 as the latest value for Q4 2025.

  • Quarterly Interest & Investment Income fell 107.01% to -$40000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.1 million through Dec 2025, down 66.77% year-over-year, with the annual reading at $1.1 million for FY2025, 66.77% down from the prior year.
  • Interest & Investment Income for Q4 2025 was -$40000.0 at Spruce Biosciences, down from $36000.0 in the prior quarter.
  • The five-year high for Interest & Investment Income was $1.4 million in Q3 2023, with the low at -$40000.0 in Q4 2025.
  • Average Interest & Investment Income over 4 years is $664937.5, with a median of $612500.0 recorded in 2024.
  • The sharpest move saw Interest & Investment Income skyrocketed 1125.96% in 2023, then plummeted 107.01% in 2025.
  • Over 4 years, Interest & Investment Income stood at $1.1 million in 2022, then increased by 20.55% to $1.3 million in 2023, then crashed by 56.74% to $571000.0 in 2024, then tumbled by 107.01% to -$40000.0 in 2025.
  • According to Business Quant data, Interest & Investment Income over the past three periods came in at -$40000.0, $36000.0, and $654000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.